Overcoming Challenges in Formulating Tablets for Pediatric Use

Overcoming Challenges in Formulating Tablets for Pediatric Use

Published on 27/12/2025

Step-by-Step Guide to Developing Pediatric Tablets with Improved Compliance

Overview:

Developing tablets for pediatric use presents unique challenges, including dose flexibility, taste masking, ease of swallowing, and safety. Children have different physiological responses, difficulty swallowing solid dosage forms, and a preference for palatable medications. Pediatric formulations must be age-appropriate, palatable, and adaptable for varying weight-based dosages.

This step-by-step guide outlines the best strategies for formulating pediatric tablets while ensuring patient compliance, safety, and regulatory adherence.

Step 1: Understanding the Challenges in Pediatric Tablet Formulation

1.1 Difficulty in Swallowing

Challenges:

  • Young children often have difficulty swallowing standard tablets.
  • Risk of choking with large solid dosage forms.

Solutions:

  • Use mini-tablets (2-4 mm diameter) for easier swallowing.
  • Develop dispersible or orally disintegrating tablets (ODTs) for rapid dissolution.

1.2 Taste Masking for Better Palatability

Challenges:

  • Many APIs have bitter or metallic tastes, reducing patient acceptance.
  • Conventional coating may not fully mask unpleasant flavors.
Pharma Tip:  Preventing Sticking During the Compression of Immediate Release Tablets

Solutions:

  • Use polymeric coatings (e.g., Eudragit® E100) for taste masking.
  • Incorporate sweeteners (sucralose, aspartame) and flavor enhancers.
  • Utilize microencapsulation to prevent direct taste perception.

1.3 Need for Flexible Dosing

Challenges:

  • Pediatric patients require weight-based dosing.
  • Standard tablets offer limited dose adjustment.

Solutions:

  • Develop scored tablets for easy dose splitting.
  • Formulate multiple strength mini-tablets that can be combined.

Step 2: Optimizing Pediatric Tablet Design

2.1 Mini-Tablets vs. Dispersible Tablets

Solution:

  • Use mini-tablets (2-3 mm) for
infants & young children.
  • Develop dispersible tablets that dissolve in water for ease of administration.
  • 2.2 ODTs for Rapid Drug Release

    Solution:

    • Use superdisintegrants (e.g., crospovidone) to enable rapid breakdown in the mouth.

    Step 3: Selecting Safe and Acceptable Excipients

    3.1 Avoiding Harmful Excipients

    Solution:

    • Replace propylene glycol and benzyl alcohol with child-safe alternatives.

    3.2 Using Pediatric-Friendly Excipients

    Solution:

    • Use isomalt as a sweetener for improved palatability.

    Step 4: Taste Masking Techniques

    4.1 Polymer Coating

    Solution:

    • Use ethylcellulose coatings to block bitter taste perception.

    4.2 Complexation with Ion-Exchange Resins

    Solution:

    • Use resin complexes (e.g., Amberlite®) to trap API taste.

    Step 5: Enhancing Tablet Disintegration for Pediatric Use

    5.1 Superdisintegrants

    Solution:

    • Use sodium starch glycolate for rapid tablet dispersion.

    5.2 Effervescent Agents

    Solution:

    • Use citric acid and sodium bicarbonate to enhance tablet breakdown.

    Step 6: Process Optimization for Pediatric Tablets

    6.1 Granulation Method Selection

    Solution:

    • Use wet granulation for uniform particle size and taste masking.

    6.2 Tablet Compression Optimization

    Solution:

    • Maintain hardness at 3-5 kp for easy disintegration.

    Step 7: Emerging Technologies in Pediatric Tablet Formulation

    7.1 3D-Printed Pediatric Tablets

    Allows for precise dose customization based on weight and age.

    7.2 AI-Driven Taste Masking

    Uses machine learning to optimize flavor profiles and excipient selection.

    7.3 Nanoparticle-Based Drug Delivery

    Improves drug bioavailability and stability in pediatric formulations.

    Step 8: Regulatory Compliance and Testing

    8.1 Compliance with ICH and FDA Pediatric Guidelines

    Solution:

    • Follow ICH E11 for pediatric formulations.

    8.2 Stability and Dissolution Testing

    Solution:

    • Conduct accelerated stability testing (40°C/75% RH) for 6 months.

    Conclusion:

    Developing pediatric-friendly tablets requires a patient-centered approach that considers ease of swallowing, taste masking, flexible dosing, and excipient safety. By integrating mini-tablet technology, orally disintegrating formulations, and AI-driven taste masking, pharmaceutical manufacturers can enhance medication adherence in children while ensuring regulatory compliance and therapeutic efficacy.

    If you find our Articles useful
    Add us as preferred source on Google
    If you find our Articles useful
    Add us as preferred source on Google